Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
SeaStar Medical Holding Corporation - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ICU
Nasdaq
3840
seastarmedical.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for SeaStar Medical Holding Corporation
SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026
- Aug 6th, 2026 6:35 am
SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)
- Jul 14th, 2026 6:34 am
Q2 Virtual Investor Summit Presentations Now Available On Demand
- Jun 30th, 2026 11:20 am
Q2 Investor Summit Virtual Live Wednesday June 24
- Jun 23rd, 2026 1:40 pm
SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
- Jun 23rd, 2026 6:25 am
SeaStar Medical to Present at Upcoming Investor Summit Conference
- Jun 22nd, 2026 6:45 am
ICU: YoY Revenue Increases 69%
- May 18th, 2026 5:15 am
SeaStar Medical Holding Corporation Q2 2026 Earnings Call Summary
- May 14th, 2026 6:30 am
SeaStar Medical Holding Corp (ICU) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...
- May 13th, 2026 11:01 pm
SeaStar Medical (ICU) Q1 2026 Earnings Transcript
- May 13th, 2026 3:48 pm
Full Transcript: SeaStar Medical Holding Q1 2026 Earnings Call
- May 13th, 2026 3:20 pm
SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates
- May 13th, 2026 2:05 pm
SeaStar Medical Holding Corporation Q1 2026 Earnings Call Summary
- May 13th, 2026 6:30 am
SeaStar Medical to Report First Quarter Financial Results on May 13, 2026
- May 6th, 2026 6:20 am
ICU: Poster Presentations at AKI & CRRT 2026 Highlight SAVE Registry Data and SCD MOA
- Apr 1st, 2026 4:35 am
SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026
- Mar 30th, 2026 6:20 am
SeaStar Medical Holding Corp (ICU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
- Mar 25th, 2026 9:01 pm
SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
- Mar 25th, 2026 2:05 pm
SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026
- Mar 18th, 2026 2:05 pm
OTC Markets Hosts Virtual Investor Presentation with Eric Schlorff, CEO of SeaStar Medical, and David Bautz, PhD, Senior Analyst at Zacks SCR
- Mar 17th, 2026 9:44 am
Scroll